Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Arterra Bioscience SpA ( (IT:ARBS) ) has issued an announcement.
Arterra Bioscience S.p.A. reported a significant revenue increase of 29% as of September 30, 2025, reaching approximately 3.6 million Euros compared to the same period in 2024. This growth was primarily driven by a 34% rise in sales of cosmetic raw materials. The company is on track to meet its 2025 goals, reflecting strong operational performance and positive market positioning.
More about Arterra Bioscience SpA
Arterra Bioscience S.p.A. is a green biotech company that specializes in research and development in the field of biotechnology. The company is listed on the Euronext Growth Milan market of Borsa Italiana S.p.A. and focuses on producing cosmetic raw materials.
Average Trading Volume: 34,609
Technical Sentiment Signal: Buy
Current Market Cap: €20.77M
For detailed information about ARBS stock, go to TipRanks’ Stock Analysis page.